Invention Grant
- Patent Title: Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
-
Application No.: US16557025Application Date: 2019-08-30
-
Publication No.: US11065236B2Publication Date: 2021-07-20
- Inventor: Swaroop K. Vakkalanka , Srikant Viswanadha
- Applicant: Rhizen Pharmaceuticals SA
- Applicant Address: CH La Chaux-de-Fonds
- Assignee: Rhizen Pharmaceuticals SA
- Current Assignee: Rhizen Pharmaceuticals SA
- Current Assignee Address: CH La Chaux-de-Fonds
- Agency: Blank Rome LLP
- Priority: IN2762/CHE/2012 20121108,IN4688/CHE/2012 20121108
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/52 ; A61K45/06 ; A61K31/519
Abstract:
This present invention relates to a method of treating a autoimmune, respiratory and/or inflammatory disease or condition (e.g., psoriasis, rheumatoid arthritis, asthma, COPD). The method comprises administering a PI3K Delta inhibitor or a dual PI3K Delta-Gamma inhibitor and a PDE4 inhibitor. The present invention also relates to pharmaceutical compositions containing a PI3K Delta or dual PI3K Delta-Gamma inhibitor and a PDE4 inhibitor.
Public/Granted literature
Information query
